Canada Tightens Regulation on E-Cigarette Production and Sales

Nov.08.2022
Canada Tightens Regulation on E-Cigarette Production and Sales
Canada strengthens regulations for e-cigarette production and sales including a new excise stamp and consumer tax.

Canada is strengthening its regulatory system for the production and sale of electronic cigarette products.


Starting October 1st, manufacturers and importers of e-cigarettes in Canada are required to obtain a license or register with the Canada Revenue Agency, affix a vaping excise stamp on their products, and pay a consumption tax. From October 1st to December 31st, there will be a transition period, after which only stamped e-cigarette products can be sold at retail stores. These changes stem from amendments to the 2001 Excise Tax Act and its 2022 Federal Budget Regulations.


Robert Kreklewetz, an indirect tax, customs, and trade lawyer at Millar Kreklewetz LLP, stated that these changes, from a tax perspective, essentially mean that the federal government is treating electronic cigarettes as tobacco products.


A federal excise tax of $2.91 is imposed on 20 packs of cigarettes, while approximately two milliliters of vaping liquid would require a $1 tariff. He added that this applies to nicotine-free e-liquids.


Kreklewetz stated that when e-cigarettes first emerged, like with any new technology, the government's response and action was slow. There was a lack of regulation from a product perspective, creating a bit of a wild west situation. Similarly, there was a lack of regulation from a taxation perspective, with the exception of federal sales tax, treating e-cigarettes like any other commodity. However, there was no specific consumption tax or cigarette system in place for e-cigarettes. But now, all of that has changed.


Canada also regulates electronic cigarette products through the Tobacco and Vaping Products Act and the Food and Drugs Act, and has established regulations that limit the concentration of nicotine and prescribe packaging and labeling standards.


Kreklewetz stated that tax policies are typically aligned with public policies. He proposed imposing a consumption tax, also known as a sin tax, on electronic cigarettes because they are a less harmful alternative to smoking. This would reduce incentives for smokers to switch to electronic cigarettes.


The Canadian Ministry of Health has stated that the health risks of chemicals found in electronic cigarette products, including the main liquids used in them - vegetable glycerin and propylene glycol - are still not fully understood. While these chemicals are considered safe for use in cosmetics and sweeteners, inhaling them over a long period of time is considered "unknown and still being evaluated." Similarly, the chemicals used to flavor the vaping oils are typically used by food manufacturers and are safe for consumption, but the effects of inhaling these chemicals have not yet been thoroughly tested.


Certainly, nicotine is highly addictive. The Canadian Department of Health warns that nicotine addiction in children and adolescents can "affect memory and attention," "alter the development of their brains," lower impulse control, and cause cognitive and behavioral issues.


The Canadian Department of Health has stated in its resource on "e-cigarettes and quitting smoking" that while the best choice for smokers is to quit smoking altogether, switching to e-cigarettes will "reduce your exposure to harmful and carcinogenic chemicals" and involve "short-term health improvements." E-cigarette products only contain "a small fraction of the 7,000 chemicals found in tobacco smoke," the Canadian Department of Health noted. When using e-cigarettes to quit smoking, some evidence suggests that they are associated with higher success rates.


Kreklewetz stated that if electronic cigarettes are viewed as a means for current smokers to quit smoking and switch to nicotine replacement products, then every dollar of tax paid on electronic cigarettes is simply an economic deterrent to quitting smoking. If the cost of vaping is the same as smoking, then why would anyone want to switch?


He said, "This is the vague logic that I see in the new tax system. The federal government's way of working these days is depleting new sources of revenue. Therefore, people may see the e-cigarette tax more as a tax grab than good public policy.


Statement:


This article is compiled based on third-party information and is intended solely for industry exchanges and learning.


This article does not reflect the opinion of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in our ability to translate accurately, this article may not fully reflect the original text. Please refer to the original article for the most accurate representation.


2FIRSTS is fully aligned with the position and statements of the Chinese government on all domestic, cross-strait and international issues.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Product | JNR Launches Crown Shisha 100K for International Wholesale, Pairing 58ml Capacity With Triple-Mesh DTL Design
Product | JNR Launches Crown Shisha 100K for International Wholesale, Pairing 58ml Capacity With Triple-Mesh DTL Design
JNR released the Crown Shisha 100K on August 14, 2026, positioning the ultra-high-capacity disposable around a direct-to-lung (DTL) e-shisha experience. The device combines a 58ml e-liquid capacity, triple 1.0Ω mesh coils and a 1,300mAh rechargeable battery, with JNR claiming up to 100,000 puffs. Adjustable airflow, battery and e-liquid status displays, a leather-style exterior and a shisha-inspired sound effect further differentiate the product. JNR is currently promoting the device through international wholesale and distribution channels, while a specific first retail market has not been disclosed.
Aug.31
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26